Qingdao Kingking Applied Chemistry (002094) Stock Price, News, Quotes-Moomoo

CN Stock MarketDetailed Quotes

002094 Qingdao Kingking Applied Chemistry

Watchlist

6.88
+0.39+6.01%

Not Open Nov 19 15:00 CST

4.75BMarket Cap146.38P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Qingdao Kingking Applied Chemistry (SZSE:002094) Strong Profits May Be Masking Some Underlying Issues
Simply Wall StNov 6 17:22 ET
The recent stock price of qingdao kingking applied chemistry (002094.SZ) has already deviated from the industry fundamentals, posing investment risks.
qingdao kingking applied chemistry (002094.SZ) announced that, according to the data from the China Securities Index Website, as of October 31, 2024...
Zhitong FinanceNov 3 04:57 ET
The 61% Return This Week Takes Qingdao Kingking Applied Chemistry's (SZSE:002094) Shareholders One-year Gains to 170%
Simply Wall StNov 1 19:05 ET
Qingdao Jinwang: Report for the third quarter of 2024
SZSIOct 30 12:00 ET · Announcements
qingdao kingking applied chemistry (002094.SZ): The accumulated percentage of pledged shares by the company's controlling shareholder is 90.79%.
Qingdao Kingking Applied Chemistry (002094.SZ) announced that the company's stocks have been continuously traded for ten consecutive trading days (October 1, 2024...
Zhitong FinanceOct 24 08:36 ET
Improved Revenues Required Before Qingdao Kingking Applied Chemistry Co., Ltd. (SZSE:002094) Stock's 35% Jump Looks Justified
Simply Wall StOct 11 18:03 ET

Comments

Moomoo AI

Feb 3 18:36

Investors believe Qingdao Kingking Applied Chemistry may underperform the industry due to its declining medium-term revenue and low P/S ratio. The potential for revenue improvement doesn't justify a higher P/S ratio, possibly leading to stagnant share prices.

Little Excitement Around Qingdao Kingking Applied Chemistry Co., Ltd.'s (SZSE:002094) Revenues As Shares Take 30% Pounding

Moomoo AI

Feb 2 01:32

The 6% compound share price drop over five years reflects the company's fundamental deterioration. This long-term share price weakness may be a bad sign, but contrarian investors might see a potential turnaround.